GlassScriptPhysician profile
Larry W Blum
NPI 1053300962
$6,192.10
in general payments reported to CMS, 2019-2025
67 companies · $750 in 2025
The $750 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901 · 2020: $133 · 2021: $656 · 2022: $777 · 2023: $1,258 · 2024: $1,719 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,709 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,709.44 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $357.62 | 2019-2025 | Ultomiris |
| Ucb, INC. | $294.41 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
| Tg Therapeutics, INC. | $292.07 | 2023-2024 | |
| Amgen INC. | $262.78 | 2019-2024 | Uplizna |
| Lundbeck LLC | $249.09 | 2021-2025 | Vyepti |
| Novartis Pharmaceuticals Corporation | $240.86 | 2021-2025 | |
| Grifols USA, LLC | $221.89 | 2022-2025 | Gamunex-C |
| Csl Behring | $216.19 | 2019-2025 | Hizentra, Kcentra |
| Biogen, INC. | $212.89 | 2019-2024 | Tysabri, Vumerity, Avonex |
| Genzyme Corporation | $212.84 | 2019-2022 | |
| Neurelis, INC. | $205.47 | 2020-2025 | Valtoco |
| Emd Serono, INC. | $202.05 | 2019-2025 | Mavenclad |
| Pfizer INC. | $192.76 | 2021-2025 | |
| Eisai INC. | $181.01 | 2020-2025 | |
| Abbvie INC. | $173.24 | 2021-2025 | Duopa |
Show all 67 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Blum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.